4-((4-methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide,
AB 1010,
AB-1010,
AB1010,
kinavet CA-1,
masatinib,
masitinib,
masitinib mesylate,
masivet,
Masitinib mesylate,
1048007-93-7,
Masitinib (mesylate),
UNII-ZK89EG3A18,
ZK89EG3A18,
4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-THIAZOL-2-YLAMINO)-PHENYL]-BENZAMIDE METHANESULFONATE,
Kinavet,
Masitinib mesilate,
928671-85-6,
Masitinibmesylate,
AB 1010 mesylate,
SCHEMBL1096348,
C28H30N6OS.CH4O3S,
KS-00000TSI,
DTXSID70146747,
TXCWBWKVIZGWEQ-UHFFFAOYSA-N,
3415AH,
HY-10209A,
AKOS030238993,
CS-1593,
SB14845,
4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-pyridin-3-yl-1,3-thiazol-2-yl)amino)phenyl)benzamide methanesulfonate,
4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-pyridin-3-yl-1,3-thiazol-2-yl)amino)phenyl)benzamide methanesulphonate,
AK546960,
Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-thiazolyl)amino)phenyl)-, methanesulfonate (1:1),
Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-thiazolyl)amino)phenyl)-, methanesulphonate (1:1),
FT-0707180,
AB1010 mesylate;AB-1010 mesylate;AB 1010 mesylate,
methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide,
Masivet,
AB1010,
AB 1010,
AB-1010,
A15152,
790299-79-5,